Outbound for Biotech & Life Sciences that a scientist will respect.
Scientific buyers see through a sales pitch in one line. We build outbound that earns the attention of researchers, principal investigators, and pharma leaders with precision and credibility, then carries the deal through a long, regulated buying cycle.
Precision earns the meeting. Credibility closes it.
Outbound into life sciences fails the moment it sounds like marketing. The buyers are scientists, principal investigators, heads of R&D, procurement and regulatory leads, and they evaluate a claim the way they evaluate a result: skeptically. A vague value prop gets deleted, and an inaccurate one ends the conversation. On top of that, the cycle is long and committee-driven, with scientific, procurement, and compliance stakeholders who each have to be satisfied, and budgets tied to grants, programs, and trial phases. We build a motion that respects the reader: specific, technically literate, and patient enough to carry a deal across the years a real life-sciences purchase can take.
Outreach built for scientific buyers
Scientifically literate copy
Messaging written to be accurate and specific, the way a researcher expects, so it reads as credible rather than promotional and survives a technical eye.
Researcher and procurement mapping
We reach the scientist who specifies, the program lead who champions, and the procurement and compliance roles who sign, and sequence each to their concern.
Segmentation by science
Targeting by therapeutic area, modality, instrument or platform, and research stage, so the message fits a discovery lab and a clinical-stage sponsor differently.
Cycle and funding aware
Outreach timed to grant, program, and trial-phase windows, so you reach an account when budget and need actually align, not when a sequence fires.
Compliance-conscious outreach
Claims kept careful and evidence-led, with copy that respects regulatory sensitivity and the boundaries of what can be said before a deal is qualified.
Evidence-led angles
Reasons to reply grounded in the science and the outcome, not hype, written by senior copywriters who can hold a credible technical conversation.
How we run it for life sciences
Learn the science
We get fluent in your therapeutic area, platform, and the outcome a buyer actually cares about.
Map the committee
We identify the scientific, program, procurement, and compliance roles on each account.
Write with precision
We craft accurate, evidence-led angles per role that a scientific reader will respect.
Sequence multichannel
Email, phone, and LinkedIn timed to the science and the funding cycle, kept compliance-conscious throughout.
Hold the math
We report against the pipeline model and tune targeting and copy every week.
Built to respect a regulated industry.
Life sciences is governed by rules that do not forgive a careless claim, and your brand carries the cost of a sloppy outreach program. We treat compliance as part of the craft, not an afterthought.
- Careful, evidence-led claims with no overstated efficacy or unsupported assertions
- Outreach that honors consent norms and unsubscribe handling across regions
- Messaging reviewed against your guidelines, with sign-off paths for sensitive language
- Targeting and data sourced to respect privacy and the boundaries of regulated audiences
Proof
A life-sciences instrumentation company reached research labs its reps could not get to.
Generic outreach was bouncing off scientists who saw the pitch coming. We rebuilt the messaging to be technically precise, mapped the principal investigator and procurement roles on each account, and timed outreach to funding and program cycles. Qualified scientific conversations became a predictable line, and the copy held up to a researcher review.
A life-sciences instrumentation company. Anonymized.
3x
Qualified scientific conversations
< 12 weeks
From kickoff to consistent pipeline
Illustrative. Real metrics and named references are added with client approval.
Where this connects
Questions, answered
We write for a scientific reader: accurate, specific, and evidence-led, with a reason to reply that respects their expertise. We get fluent in your science first, so the outreach reads like a credible peer rather than a vendor, and it survives a technical eye instead of getting deleted on the first line.
Outbound your scientists will take seriously.
Book a call and we will map a precise, compliance-conscious motion to your science and your buyers.